Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Major Shareholding Notification 2015

Oct 19, 2015

65058_rns_2015-10-19_0770f916-2df0-401a-8314-48eee417b72f.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Go To Guide

Clear Form

Save User Guide Annexure Close Form 604 page 1/2 15 July 2001

Insert Agent Details

Print

Form 604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme Primary Health Care

ACN/ARSN 064 530 519

1. Details of substantial holder(1)

Name Maple-Brown Abbott Limited

ACN/ARSN (if applicable) 001 208 564

There was a change in the interests of the substantial holder on 16 / / 10 15 The previous notice was given to the company on 31 / / 07 14 The previous notice was dated 29 / / 07 14

2. Previous and present voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:

Class of securities (4) Previous notice
Person's votes
Voting power (5)
Previous notice
Person's votes
Voting power (5)
Present notice Present notice
Voting power (5) Person's votes Voting power (5)
Fully paid ordinary 30,900,993
6.11%
37,258,198
7.15%
shares

3. Changes in relevant interests

Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:

Date of
change
Person whose
relevant interest
changed
Nature of
change (6)
Consideration
given in relation
to change (7)
Class and
number of
securities
affected
Person's votes
affected
16/10/15 Refer Annexure A Purchases ----------Refer Annexure B------------

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of
relevant
interest
Registered
holder of
securities
Person entitled
to be registered
as holder (8)
Nature of
relevant
interest (6)
Class and
number of
securities
Person's votes
--------- ---------------- Refer Annexure C-------------- --------- -------------

Insert Agent Details Go To Guide Clear Form Print

Save

User Guide Annexure Close Form 604 page 2/2 15 July 2001

|5. Changes
The persons w
interests in th
6. Addresse
The addresses|e
print name
capacity
sign here
date
/
/
in association
ho have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting
e company or scheme are as follows:
Name and ACN/ARSN (if applicable)
Nature of association
s
of persons named in this form are as follows:
Name
Address
DIRECTIONS
ere are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an
ty trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to
ughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the
.
the definition of "associate" in section 9 of the Corporations Act 2001.
the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
voting shares of a company constitute one class unless divided into separate classes.
person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
de details of:
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any
document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or
arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to
which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
ils of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become<br>led to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be<br>ded of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom<br>relevant interest was acquired.<br>e substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>details, if appropriate, of the present association and any change in that association since the last substantial holding notice.<br>N/A<br>N/A<br>Maple-Brown Abbott Ltd<br>Level 31, 259 George Street, Sydney NSW 2000<br>Dean Smedley<br>Company Secretary<br>20<br>10<br>15|**e**<br>print name<br>capacity<br>**sign here**<br>date<br>/<br>/<br>**in association**<br>ho have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting<br>e company or scheme are as follows:<br>Name and ACN/ARSN (if applicable)<br>Nature of association<br>**s**<br>of persons named in this form are as follows:<br>Name<br>Address<br>**DIRECTIONS**<br>ere are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an<br>ty trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to<br>ughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the<br>.<br>the definition of "associate" in section 9 of the Corporations Act 2001.<br>the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.<br>voting shares of a company constitute one class unless divided into separate classes.<br>person's votes divided by the total votes in the body corporate or scheme multiplied by 100.<br>de details of:<br>any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any<br>document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or<br>arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and<br>any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to<br>which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).<br>the definition of "relevant agreement" in section 9 of the Corporations Act 2001.<br>ils of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become
led to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be
ded of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom
relevant interest was acquired.
e substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".
details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
N/A
N/A
Maple-Brown Abbott Ltd
Level 31, 259 George Street, Sydney NSW 2000
Dean Smedley
Company Secretary
20
10
15|e
print name
capacity
sign here
date
/
/
in association
ho have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting
e company or scheme are as follows:
Name and ACN/ARSN (if applicable)
Nature of association
s
of persons named in this form are as follows:
Name
Address
DIRECTIONS
ere are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an
ty trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to
ughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the
.
the definition of "associate" in section 9 of the Corporations Act 2001.
the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
voting shares of a company constitute one class unless divided into separate classes.
person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
de details of:
any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any
document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or
arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to
which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
ils of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become<br>led to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be<br>ded of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom<br>relevant interest was acquired.<br>e substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".<br>details, if appropriate, of the present association and any change in that association since the last substantial holding notice.<br>N/A<br>N/A<br>Maple-Brown Abbott Ltd<br>Level 31, 259 George Street, Sydney NSW 2000<br>Dean Smedley<br>Company Secretary<br>20<br>10<br>15| |---|---|---|---| ||Name||Address| ||Maple-Brown|Abbott Ltd|Level 31, 259 George Street, Sydney NSW 2000`|
|||||
|||||
|Signatur
(1)
If th
equi
thro
form
(2)
See
(3)
See
(4)
The
(5)
The
(6)
Inclu
(a)
(b)
See
(7)
Deta
entit
inclu
the
(8)
If th
(9)
Give||||

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:

6. Addresses

The addresses of persons named in this form are as follows:

Signature

  • (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

  • (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

  • (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

  • (4) The voting shares of a company constitute one class unless divided into separate classes.

  • (5) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.

  • (6) Include details of:

  • (a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

  • (b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).

  • See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

  • (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, becom`e entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

  • (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".

  • (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.

Annexure

Annexure A

Primary Health Care Registered Shareholdings as at 29 July 2014

Registered Name
National Nominees Limited
J.P. Morgan Nominees Australia Limited
RBC Investor Services Australia Nominees Pty Limited
State Street Australia Ltd
Citicorp Nominees Pty Ltd
M F Custodians
Brown Brothers Harriman
The Northern Trust Company
Brown Brothers Harriman Infomediary
Rossler Superannuation Fund
Diana Florence Pty Ltd
Address
GPO Box 1406M, MELBOURNE VIC 3001
Level 18, JP Morgan House, 85 Castlereagh Street, SYDNEY NSW 2000
Level 47, 2 Park Street, SYDNEY NSW 2000
Unlisted Unit Trust Department, State Street Australia Limited, 420 George Street, SYDNEY NSW 2000
Level 2, 350 Collins Street, MELBOURNE VIC 3001
Level 7, 171 Collins Street, MELBOURNE VIC 3000
40 Water Street, BOSTON MA 02109
46th Floor, UOB Plazza 1, 80 Raffles Place, SINGAPORE SINGAPORE 048624
40 Water Street, BOSTON MASSACHUSETTS 02109
c/- Maple-Brown Abbott Limited, Level 31, 259 George Street, SYDNEY NSW 2000
Holding
10,646,107
10,127,532
4,367,468
4,162,214
653,100
363,100
236,322
229,334
82,947
30,000
2,869

30,900,993

Annexure B

Primary Health Care Net Trades between 30 July 2014 and 16 October 2015

Date
Quantity
31-Jul-2014
120,634
04-Aug-2014
4,500
12-Aug-2014
(638,300)
27-Aug-2014
754,657
29-Aug-2014
189,454
01-Sep-2014
100,000
02-Sep-2014
70,342
03-Sep-2014
158,363
08-Sep-2014
270,000
11-Sep-2014
375,065
12-Sep-2014
180,000
15-Sep-2014
15,000
17-Sep-2014
(1,338,000)
19-Sep-2014
(9,557)
26-Sep-2014
54,242
07-Oct-2014
14,507
13-Oct-2014
118,739
14-Oct-2014
16,702
03-Nov-2014
220,000
11-Nov-2014
202,834
17-Nov-2014
98,498
21-Nov-2014
52,476
12-Dec-2014
30,000
15-Dec-2014
8,000
14-Jan-2015
205,001
21-Jan-2015
101,296
22-Jan-2015
151,663
28-Jan-2015
21,036
30-Jan-2015
288,563
02-Feb-2015
4,898
05-Feb-2015
21,788
25-Feb-2015
200,000
26-Feb-2015
110,000
02-Mar-2015
134,094
03-Mar-2015
148,800
18-Mar-2015
41,015
07-Apr-2015
(1,362)
08-Apr-2015
(293,892)
09-Apr-2015
(163,089)
10-Apr-2015
(38,700)
17-Apr-2015
(56,662)
23-Apr-2015
(1)
29-Apr-2015
(30,000)
Consideration
586,362.06
21,534.11
(3,063,840.00)
3,273,821.40
857,722.34
446,419.96
315,543.46
720,881.66
1,211,274.87
1,659,630.15
798,107.98
66,042.57
(5,753,400.00)
(42,624.22)
237,852.16
61,371.11
491,044.50
69,690.51
1,041,696.81
937,004.50
454,983.93
237,870.10
136,752.26
36,525.74
932,184.24
448,807.21
673,547.45
95,924.16
1,345,055.31
22,666.39
104,874.12
914,427.77
504,435.40
647,814.67
725,559.57
199,951.47
(7,354.80)
(1,584,029.99)
(861,654.31)
(204,117.56)
(301,177.93)
(5.07)
(151,762.50)

Annexure B

Primary Health Care Net Trades between 30 July 2014 and 16 October 2015

Date
Quantity
07-May-2015
88,677
13-May-2015
(1,335,000)
29-Jun-2015
(44,400)
01-Jul-2015
(248,265)
02-Jul-2015
(330,000)
03-Jul-2015
(215,000)
07-Jul-2015
(138,814)
09-Jul-2015
(65,000)
15-Jul-2015
(50,000)
16-Jul-2015
723,918
17-Jul-2015
20,045
29-Jul-2015
278,000
30-Jul-2015
417,000
03-Aug-2015
176,243
04-Aug-2015
153,757
10-Aug-2015
(150,000)
12-Aug-2015
(500,000)
13-Aug-2015
(75,000)
17-Aug-2015
10,000
20-Aug-2015
229,251
21-Aug-2015
495,749
24-Aug-2015
421,000
25-Aug-2015
597,302
26-Aug-2015
773,657
02-Sep-2015
179,735
09-Sep-2015
77,478
14-Sep-2015
152
23-Sep-2015
100,000
25-Sep-2015
49,100
28-Sep-2015
100,000
29-Sep-2015
291,165
30-Sep-2015
10,000
01-Oct-2015
200,000
06-Oct-2015
495,000
07-Oct-2015
385,000
09-Oct-2015
85,500
12-Oct-2015
360,500
13-Oct-2015
490,790
14-Oct-2015
150,000
16-Oct-2015
237,061
6,357,205
Consideration
446,242.81
(6,675,000.00)
(219,409.68)
(1,265,273.39)
(1,707,957.17)
(1,101,138.99)
(698,280.01)
(325,304.77)
(259,194.57)
3,430,632.15
96,153.70
1,293,872.26
1,930,820.17
811,053.02
710,055.55
(671,480.48)
(2,312,727.30)
(339,075.91)
43,923.27
966,695.64
2,083,198.95
1,720,699.44
2,526,997.86
3,165,775.04
737,850.23
322,700.59
621.68
396,435.60
194,635.13
394,195.33
1,105,301.12
37,966.72
762,290.55
1,857,234.88
1,427,865.41
319,676.59
1,338,374.13
1,858,243.75
578,334.54
919,270.03
24,209,687.43

Annexure C

Primary Health Care Registered Shareholdings as at 16 October 2015

Registered Name
National Nominees Limited
J.P. Morgan Nominees Australia Limited
RBC Investor Services Australia Nominees Pty Limited
State Street Australia Ltd
Citicorp Nominees Pty Ltd
Brown Brothers Harriman
The Northern Trust Company
M F Custodians
Brown Brothers Harriman Infomediary
Rossler Superannuation Fund
Fonthill Pty Ltd
Diana Florence Pty Ltd
Address
GPO Box 1406M, MELBOURNE VIC 3001
Level 18, JP Morgan House, 85 Castlereagh Street, SYDNEY NSW 2000
Level 47, 2 Park Street, SYDNEY NSW 2000
Unlisted Unit Trust Department, State Street Australia Limited, 420 George Street, SYDNEY NSW 2000
Level 2, 350 Collins Street, MELBOURNE VIC 3001
40 Water Street, BOSTON MA 02109
46th Floor, UOB Plazza 1, 80 Raffles Place, SINGAPORE SINGAPORE 048624
Level 7, 171 Collins Street, MELBOURNE VIC 3000
40 Water Street, BOSTON MASSACHUSETTS 02109
c/- Maple-Brown Abbott Limited, Level 31, 259 George Street, SYDNEY NSW 2000
c/- Maple-Brown Abbott Limited, Level 31, 259 George Street, SYDNEY NSW 2000
Holding
14,026,973
10,657,723
5,287,106
4,494,560
779,120
608,824
554,043
520,000
292,480
30,000
4,500
2,869
37,258,198

National Nominees Limited